Document is current
Any future updates will be listed below
-
Authors
Sumi, Hirofumi
Tominaga, Naoto https://orcid.org/0000-0002-3699-7418
- License Information
-
More Information
Article History
Received: 19 September 2023
Accepted: 6 October 2023
First Online: 17 October 2023
Declarations
:
: Naoto Tominaga received honorariums from Otsuka Pharmaceutical Co., Ltd., for being a speaker on a drug not mentioned in this letter to the editor. The authors declare no conflicts of interest.
